Literature DB >> 25134833

Paediatrics: A 24 h urine collection is essential in nephrolithiasis evaluation.

Boris Chertin1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25134833     DOI： 10.1038/nrurol.2014.215

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  7 in total

1.  Increased water intake as a prevention strategy for recurrent urolithiasis: major impact of compliance on cost-effectiveness.

Authors:  Y Lotan; I Buendia Jiménez; I Lenoir-Wijnkoop; M Daudon; L Molinier; I Tack; M J C Nuijten
Journal:  J Urol       Date:  2012-09-24       Impact factor: 7.450

2.  Underuse of 24-hour urine collection among children with incident urinary stones: a quality-of-care concern?

Authors:  Jonathan S Ellison; Samuel R Kaufman; Kate H Kraft; J Stuart Wolf; Brent K Hollenbeck; John M Hollingsworth
Journal:  Urology       Date:  2014-06-21       Impact factor: 2.649

Review 3.  An update on the changing epidemiology and metabolic risk factors in pediatric kidney stone disease.

Authors:  David J Sas
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-07       Impact factor: 8.237

4.  The risk of recurrent urolithiasis in children is dependent on urinary calcium and citrate.

Authors:  William R DeFoor; Elizabeth Jackson; Eugene Minevich; Alexandre Caillat; Pramod Reddy; Curtis Sheldon; John Asplin
Journal:  Urology       Date:  2010-01-27       Impact factor: 2.649

5.  Cost-effectiveness of primary prevention strategies for nephrolithiasis.

Authors:  Yair Lotan; Margaret S Pearle
Journal:  J Urol       Date:  2011-06-16       Impact factor: 7.450

Review 6.  Current management of paediatric urolithiasis.

Authors:  Ehud Gnessin; Leonid Chertin; Boris Chertin
Journal:  Pediatr Surg Int       Date:  2012-04-28       Impact factor: 1.827

7.  A new approach to the diagnosis of children's urolithiasis based on the Bonn Risk Index.

Authors:  Tadeusz Porowski; Walentyna Zoch-Zwierz; Jerzy Konstantynowicz; Katarzyna Taranta-Janusz
Journal:  Pediatr Nephrol       Date:  2008-03-12       Impact factor: 3.714
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.